Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2009
12/22/2009US7635774 Benzimidazole derivatives
12/22/2009US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease
12/22/2009CA2447166C Delivery of erectile dysfunction drugs through an inhalation route
12/22/2009CA2446990C Delivery of sedative-hypnotics through an inhalation route
12/22/2009CA2446917C Delivery of antipsychotics through an inhalation route
12/22/2009CA2446916C Delivery of opioids through an inhalation route
12/22/2009CA2423806C Modified carbocyanine dyes and their conjugates
12/22/2009CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009CA2345297C Synthetic analogs of ecteinascidin-743
12/22/2009CA2290744C Cyclic diamine compounds and medicine containing the same
12/22/2009CA2262435C Preparation of sterically hindered amine ethers
12/17/2009WO2009151598A1 Diazacarbazoles and methods of use
12/17/2009WO2009151589A1 Diazacarbazoles and methods of use
12/17/2009WO2009150388A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009WO2009150381A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same
12/17/2009WO2009150240A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
12/17/2009WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009WO2009150139A2 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
12/17/2009WO2009150138A1 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
12/17/2009WO2009150129A1 Heterocyclic derivatives as hdac inhibitors
12/17/2009WO2009149820A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009WO2009149819A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009WO2009130710A3 A process for the preparation of paliperidone intermediates
12/17/2009WO2009129401A8 Kinase inhibitors
12/17/2009WO2009109987A3 Fused pyrimidine derivatives as trpv3 modulators
12/17/2009WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors
12/17/2009WO2008144931A8 Compositions and methods for modulating gated ion channels
12/17/2009US20090312553 N-type semiconductor materials for thin film transistors
12/17/2009US20090312549 Method of preparation of azaindole derivatives
12/17/2009US20090312548 Modified pictet-spengler reaction and products prepared therefrom
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312366 Novel p2x7r antagonists and their use
12/17/2009US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009US20090312356 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom
12/17/2009US20090312349 Anti-inflammatory medicaments
12/17/2009US20090312335 Hiv Integrase Inhibitors
12/17/2009US20090312326 Substituted imidazoles
12/17/2009US20090312321 Compositions and methods for fgf receptor kinases inhibitors
12/17/2009US20090312306 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
12/17/2009US20090312304 Organic compounds
12/17/2009US20090312288 Kinase inhibitors
12/17/2009CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009CA2727669A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009CA2727245A1 Imidazole derivatives useful as inhibitors of faah
12/17/2009CA2727243A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists
12/17/2009CA2727062A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
12/17/2009CA2727032A1 Novel tricyclic compounds
12/17/2009CA2726114A1 Diazacarbazoles and methods of use
12/17/2009CA2725754A1 Diazacarbazoles and methods of use
12/17/2009CA2725093A1 Azacarboline derivatives, preparation method thereof and therapeutic us of same
12/16/2009EP2133352A2 Crystal form of 9-hydroxy-risperidone (paliperidone)
12/16/2009EP2133351A2 Crystal form of 9-hydroxy-risperidone (paliperidone)
12/16/2009EP2133350A2 A method for the preparation of an enantiomerically pure benzazepine
12/16/2009EP2133349A1 Kinase inhibitors
12/16/2009EP2133340A1 Novel benzazepine derivatives
12/16/2009EP2133336A1 Modified metal complexes and use thereof
12/16/2009EP2133334A1 Heterocyclic derivatives as HDAC inhibitors
12/16/2009EP2132196A1 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
12/16/2009EP2132157A1 Novel condensed ring aromatic compound and organic light-emitting device having the same
12/16/2009EP2131656A2 Phthalazine derivatives
12/16/2009EP1912644B1 N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof
12/16/2009EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
12/16/2009CN101605793A Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
12/16/2009CN101605792A Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
12/16/2009CN101605791A 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
12/16/2009CN101605790A New aminopyrrolo[1,2-a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
12/16/2009CN101605789A Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor
12/16/2009CN101605788A Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
12/16/2009CN101605787A Compounds modulating c-fms and/or c-kit activity and uses therefor
12/16/2009CN101605786A Imidazopyridine inhibitors of iap
12/16/2009CN101605785A Pyrido-pyrazine derivatives useful as herbicidal compounds
12/16/2009CN101605780A New 2, 4-dianilinopyrimidines, preparation thereof as drugs,pharmaceutical compositions and use thereof essentially as IKK inhibitors
12/16/2009CN101605544A CRTH2 antagonists
12/16/2009CN101602763A Preparation method of oxymatrine
12/16/2009CN101602741A Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
12/16/2009CN101602731A Metalloproteinase inhibitors
12/16/2009CN100569773C Novel azaindole thiazolinones as anti-cancer agents
12/16/2009CN100569772C Azaindoles useful as inhibitors of JAK and other protein kinases
12/16/2009CN100569769C Compounds with antibacterial activity
12/15/2009US7632948 reacting 8-amino-1,2,3,4-tetrahydro-isoquinoline with chloral hydrate and hydroxylamine hydrochloride to give an N-(1,2,3,4-tetrahydro-isoquinolin-8-yl)-2-hydroxyimino-acetamide, adding H2SO4 to provide a 2,3-dioxo-2,3,6,7,8,9-hexahydro-1H-pyrrolo[3,2-h]isoquinoline, finally reacting with butyrolactone
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632839 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction
12/15/2009US7632831 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/15/2009US7632578 Containing imidazo-pyridine compound
12/10/2009WO2009149139A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2009WO2009148341A1 Process for preparation of tadalafil
12/10/2009WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009WO2009147476A1 Novel pde inhibitors, pharmaceutical compositions containing them and processes for their preparation
12/10/2009WO2009147237A1 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
12/10/2009WO2009147190A1 Novel compounds
12/10/2009WO2009147167A1 Indane derivatives as ampa receptor modulators
12/10/2009WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists
12/10/2009WO2009146696A1 Use of indole-3-carboxylic esters for inhibiting microsomal prostaglandin e2 synthase
12/10/2009WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009US20090306388 Method for substituted ih-imidazo[4,5-c] pyridines
12/10/2009US20090306386 Plant Extract Obtained by an Extraction Method by Means of Solvents of Plant Origin
12/10/2009US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods